Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon | 4 | 2008 | 54 | 0.660 |
Why?
|
| Thrombomodulin | 3 | 2008 | 17 | 0.520 |
Why?
|
| Polytetrafluoroethylene | 2 | 2008 | 18 | 0.470 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2008 | 45 | 0.310 |
Why?
|
| Femoral Artery | 2 | 2008 | 99 | 0.310 |
Why?
|
| Carotid Artery Injuries | 1 | 2008 | 12 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2008 | 153 | 0.270 |
Why?
|
| Drug-Eluting Stents | 1 | 2008 | 66 | 0.260 |
Why?
|
| Cardiovascular Agents | 1 | 2008 | 104 | 0.260 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 98 | 0.250 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 77 | 0.250 |
Why?
|
| Atherosclerosis | 1 | 2008 | 156 | 0.250 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 117 | 0.240 |
Why?
|
| Stents | 1 | 2007 | 493 | 0.190 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 704 | 0.170 |
Why?
|
| Hyperplasia | 4 | 2008 | 89 | 0.170 |
Why?
|
| Tunica Intima | 2 | 2008 | 15 | 0.120 |
Why?
|
| Time Factors | 4 | 2012 | 3724 | 0.100 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 37 | 0.090 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 116 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 2238 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2012 | 244 | 0.080 |
Why?
|
| Rabbits | 2 | 2008 | 333 | 0.080 |
Why?
|
| Tunica Media | 1 | 2008 | 5 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2008 | 40 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 37 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 156 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2012 | 728 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2008 | 175 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2008 | 224 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2007 | 61 | 0.060 |
Why?
|
| Swine | 1 | 2008 | 394 | 0.060 |
Why?
|
| Male | 7 | 2012 | 30294 | 0.060 |
Why?
|
| Aneurysm, False | 1 | 2007 | 50 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 223 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 869 | 0.060 |
Why?
|
| Radiography | 1 | 2008 | 552 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2004 | 110 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 2007 | 147 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2008 | 575 | 0.060 |
Why?
|
| Lipids | 1 | 2008 | 319 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2007 | 212 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2012 | 808 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 1176 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 32 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 35 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2003 | 44 | 0.050 |
Why?
|
| Animals | 4 | 2008 | 20961 | 0.050 |
Why?
|
| Immunologic Techniques | 1 | 2002 | 11 | 0.050 |
Why?
|
| Electron Probe Microanalysis | 1 | 2002 | 6 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2002 | 30 | 0.050 |
Why?
|
| Protein C | 1 | 2002 | 26 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 126 | 0.040 |
Why?
|
| Inflammation | 1 | 2008 | 1162 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2478 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1621 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2007 | 1294 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1669 | 0.040 |
Why?
|
| Humans | 6 | 2012 | 64238 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2007 | 6726 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2007 | 5691 | 0.030 |
Why?
|
| Mice | 1 | 2008 | 11003 | 0.030 |
Why?
|
| Adult | 2 | 2012 | 17116 | 0.030 |
Why?
|
| Aged | 2 | 2007 | 14648 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2012 | 63 | 0.020 |
Why?
|
| Female | 3 | 2012 | 33350 | 0.020 |
Why?
|
| Middle Aged | 1 | 2007 | 17898 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 215 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 297 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 625 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 304 | 0.010 |
Why?
|
| Computational Biology | 1 | 2007 | 357 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2004 | 134 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 251 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 783 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 2005 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 379 | 0.010 |
Why?
|
| Thrombosis | 1 | 2004 | 198 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 930 | 0.010 |
Why?
|
| Massachusetts | 1 | 2003 | 2094 | 0.010 |
Why?
|